A Compassionate Use Study of Engineered Skin Substitute in the Treatment of Life-Threatening Pediatric Severe Burns

Trial Profile

A Compassionate Use Study of Engineered Skin Substitute in the Treatment of Life-Threatening Pediatric Severe Burns

Completed
Phase of Trial: Clinical Phase Unknown

Latest Information Update: 27 Aug 2016

At a glance

  • Drugs Human skin replacement Amarantus Bioscience (Primary)
  • Indications Burns
  • Focus Adverse reactions; Expanded access; Therapeutic Use
  • Most Recent Events

    • 27 Aug 2016 New trial record
    • 08 Aug 2016 According to an Amarantus media release, results from this study were published in Journal of Burn Care and Research.
    • 08 Aug 2016 Results published in an Amarantus Bioscience Holdings media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top